Title

This activity utilizes a case-led format focusing on complex GERD.

Case topics include:

Case 1: Ongoing Symptomatic GERD Despite PPI Therapy.

Case 2: Complex GERD: Managing Patients with Co-Morbidities.

Case 3: Managing the Sensitive Gut: The NERD/GERD/IBS Interface.

After completing this activity the participant should be able to:

• Define the clinical presentation of complex GERD and the demographic factors driving its increasing incidence.
• Specify the association of inadequately controlled, symptomatic GERD with complications such as sleep disturbance, causing a deteriorating quality-of-life, and esophageal complications such as severe GERD, BE and possible EAC.
• Describe the management of patients with GERD co-morbidities and evaluate patients with extra-esophageal complaints who may have GERD as an underlying factor and may therefore respond to PPI therapy.
• Identify possible shortcomings with currently available PPIs and describe how the evolution of longer acting PPI therapy might be clinically beneficial in these patients.
• Describe the possible association between NERD/GERD and IBS and take a holistic approach to the management of these patients.

David A. Peura, MD, AGAF, MACG; William D. Chey, MD, AGAF, FACG; Hashem B. El-Serag, MD, MPH; Michael F. Vaezi, MD, PhD, FACG

Jointly sponsored by the University of California, Irvine School of Medicine and Strategic Consultants International. 

This activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc

To view additional topics, visit www.TheGut.org.

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.

Contact
For further information or to submit a program for consideration, please contact Dianne Bach (301-941-2623 or dbach@gastro.org) or Michael Stolar (301-941-2608 or mstolar@gastro.org).

 
TheGut.org is a gateway offering GI professionals greater and easier access to CME programming. The site houses programs that have been developed by ACCME-accredited organizations other than the AGA Institute. Topics will cover the full spectrum including IBD, new technology, gastrointestinal cancer and practice management. The AGA Institute is not involved in content development but reviews all programs posted on the site. Postings are available for viewing for up to one year.
 

Representatives from the AGA , MGMA, as well as Joel Brill, MD, AGAF, discussed the impact the elimination of inpatient and outpatient consultation codes could have on your practice including your practice’s revenue, evaluation and management coding and providers’ documentation requirements. Other coding changes for 2010 where also reviewed.

If you missed this Webinar, it is available on demand to download.  In addition to the Webinar download, Q&A that was not recorded during the Webinar, is available for free here.

This Webinar covers:

• Why Medicare decided to eliminate the consultation codes and how that will affect the operation of the gastroenterology practice.
• How to calculate the financial impact on your practice.
• The additional gastroenterology coding changes for 2010.

AGA/MGMA Member: $149
Nonmember: $199

AGA members receive a $50 discount! Before purchasing the Webinar download, login to access the discount code to be used at the time of ordering.
 

This Webinar is jointly sponsored by the AGA Institute and MGMA.

Patients with IBD are faced with unique nutritional challenges. In order to successfully manage patients with IBD, gastroenterologists must recognize and be familiar with the nutritional needs that their patients require.

Nutrition and IBD addresses the concern of malnutrition in patients with IBD, the current available treatments and what the future holds for this issue.

Each online module includes slides with corresponding audio delivered by subject experts as well as, pre- and post-test questions. A score report will be provided upon completion.

The modules are part of the Nutrition Toolkit Series, a component of the AGA Institute’s nutrition and obesity initiative. The initiative will include access to AGA Institute obesity-related educational materials and suggested Web sites that offer tools such as nutritional calculators and meal planning tips. Additional modules on obesity and nutrition related issues are in development and will be made available throughout the year.

Available only to AGA members. To become a member, visit www.gastro.org/membership today.

Mark H. DeLegge, MD, AGAF
Professor of Medicine
Digestive Disease Center
Medical University of South Carolina

As a part of the Hepatitis C Resource Center, this CME Expert Column Series explores the latest issues related to the ongoing challenges of managing hepatitis C, with a view toward how the emerging therapeutic landscape may help address these challenges and help to improve the long-term outcomes of these patients.

About the Hepatitis C Resource Center

The Hepatitis C Resource Center is designed to provide health-care providers data which has been translated into practical ways that can help them change how they diagnose and treat patients with hepatitis C.
 

Upon completion of this activity, participants will be able to:

• Summarize the latest data on the molecular virology of the hepatitis C virus with a view toward the implications for the development of targeted pharmacologic interventions.
• Explain the importance of early treatment in hepatitis C.

View article.

This activity is supported by individual education grant from Vertex Pharmaceuticals Inc.

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Each physician should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
 
Zobair M. Younossi, MD, MPH
Executive Director of Research; Executive Director, Center for Liver Diseases; Professor of Medicine, VCU-Inova Campus, Inova Health System, Falls Church, Virginia
Disclosure: Zobair M. Younossi, MD, MPH, has disclosed the following relevant financial relationships:
Received grant/research support from: Vertex Pharmaceuticals Incorporated; Schering-Plough Corporation; Roche Laboratories Inc.; Human Genome Sciences, Inc.; Biolex; Wyeth Pharmaceuticals Inc.; Gilead Sciences, Inc.

Dr. Younossi will discuss therapeutic products that have not been approved by the US Food and Drug Administration and/or off-label uses of approved products.

Maria L. Gaiso, PhD
Scientific Director, MedscapeCME
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.

Laurie E. Scudder, MS, NP
Accreditation Coordinator, Continuing Professional Education Department, MedscapeCME; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers, Baltimore City Public Schools, Baltimore, Maryland
Disclosure: Laurie E. Scudder, MS, NP, has disclosed no relevant financial relationships.

As a part of the Hepatitis C Resource Center, this CME Expert Column Series reviews the approach to evaluating and managing adult and pediatric patients with HCV infection.

About the Hepatitis C Resource Center

The Hepatitis C Resource Center is designed to provide health-care providers data which has been translated into practical ways that can help them change how they diagnose and treat patients with hepatitis C.
 

Upon completion of this activity, participants will be able to:

• Review the epidemiology/transmission, immunology and clinical manifestations of hepatitis C infection in pediatric patients vs adults.
• Differentiate the challenges in the evaluation/diagnosis of the pediatric vs adult patient with hepatitis C.
• Discuss treatment challenges/options for hepatitis C in pediatric patients vs adults.

View article.

This activity is supported by individual education grant from Vertex Pharmaceuticals Inc.

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Each physician should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
 
Victoria Sheen, MD
Resident, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles
Disclosure: Victoria Sheen, MD, has disclosed no relevant financial relationships.
Dr. Sheen will discuss therapeutic products that have not been approved by the US Food and Drug Administration and/or off-label uses of approved products.

Sammy Saab, MD, MPH
Associate Professor of Medicine and Surgery; David Geffen School of Medicine, University of California, Los Angeles
Disclosure: Sammy Saab, MD, MPH, has disclosed the following relevant financial relationships:
Received grant/research support from: Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Roche; Schering-Plough Corporation; Three Rivers Pharmaceuticals
Served as a consultant for: Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Roche; Schering-Plough Corporation; Three Rivers Pharmaceuticals
Served as a speaker or member of a speakers bureau for: Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Roche; Schering-Plough Corporation; Three Rivers Pharmaceuticals
Dr. Saab will discuss therapeutic products that have not been approved by the US Food and Drug Administration and/or off-label uses of approved products.

Maria L. Gaiso, PhD
Scientific Director, MedscapeCME
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.

Laurie E. Scudder, MS, NP
Accreditation Coordinator, Continuing Professional Education Department, MedscapeCME; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers, Baltimore City Public Schools, Baltimore, Maryland
Disclosure: Laurie E. Scudder, MS, NP, has disclosed no relevant financial relationships.
 

This monograph recaps this cutting-edge information and interprets how these data will affect clinicians’ ability to provide optimal care for patients with these syndromes.

Upon completion of this activity, participants will be able to:

• Identify and implement the diagnostic and management recommendations of the latest US national guidelines on IBS.
• Assess the latest evidence on diagnosis and management of chronic constipation.
• Utilize the recommendations of the recent AGA Institute medical position statement on GERD to formulate strategies to diagnose and treat challenging patients.
• Analyze the challenges surrounding the management of Barrett’s esophagus and extraesophageal manifestations of GERD.

Sponsored by the AGA Institute.

This activity is supported by educational grants from:

Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals North America, Inc.

A presentation from the 2009 Celiac Disease: Broadening Horizons, held Sept. 11 and 12, in Chicago, IL.

Ciaran P. Kelly, MD AGAF
Associate Professor of Medicine
Division of Gastroenterology
Beth Israel Deaconness Medical Center
Harvard Medical School

This course was funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

A presentation from the 2009 Celiac Disease: Broadening Horizons, held Sept. 11 and 12, in Chicago, IL.

Chris J.J. Mulder, MD, PhD
Professor of Gastroenterology Head, Department of Gastroenterology and Hepatology
VU University Medical Center
Amsterdam, Netherlands

This course was funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

Cynthia Kenyon, PhD, director of the Hillblom Center for the Biology of Aging, department of biochemistry and biophysics at UCSF, delivered the AGA Foundation's Morton I. Grossman Distinguished Lectureship at DDW 2009. Her lecture is titled "From Worms to Mammals: Genes and Cells That Regulate the Aging Process."

In 1993, Dr. Kenyon and colleagues' discovery that a single-gene mutation could double the lifespan of C. elegans sparked an intensive study of the molecular biology of aging. These findings have now led to the discovery that an evolutionarily conserved hormone signaling system controls aging in other organisms as well, including mammals.

The Morton I. Grossman Lecture was established in 1989 by a group of UCLA Center for Ulcer Research and Education (CURE) Digestive Disease Research Center investigators and alumni wishing to commemorate the contributions of CURE's founder and first director. Dr. Morton I. Grossman is considered the father of modern gastrointestinal endocrine physiology. His most important contributions lay in defining the secretory mechanisms of the stomach and pancreas and the actions of regulatory gastrointestinal peptides.

The AGA Institute offered a series of three Webinars that were designed to educate physicians and nurses on the procedure and making each one a success.

Archived Webinars:

• Capsule Endoscopy in Special Situations
• Expanded Indications
• Normal Variants: Distinguishing Between Normal and Abnormal Images
  

Nuzhat Ahmad, MD
Associate Director of Endoscopy
Hospital of University of Pennsylvania

Sponsored by the AGA Institute. This program is supported by an educational grant from Given Imaging.

As a part of the Hepatitis C Resource Center, this CME Expert Column Series offers insight into a leading GI thought leader’s perspective on selecting therapies to treat hepatitis C.

About the Hepatitis C Resource Center

The Hepatitis C Resource Center is designed to provide health-care providers data which has been translated into practical ways that can help them change how they diagnose and treat patients with hepatitis C.
 

Upon completion of this activity, participants will be able to:

• Review current knowledge of the structure and replication process of the hepatitis C virus.
• Examine the implications for the development of targeted therapies in the treatment of hepatitis C.

View article.

This activity is supported by individual education grant from Vertex Pharmaceuticals Inc.

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Each physician should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
 
Nancy S. Reau, MD
Assistant Professor, Internal Medicine/Gastroenterology, University of Chicago, Chicago, Illinois
Nancy S. Reau, MD, has disclosed that she has served as an advisor or consultant for Gilead Sciences, Inc. and Bristol-Myers Squibb Company.

Maria L. Gaiso, PhD
Scientific Director, Medscape CME
Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.

Laurie E. Scudder, MS, NP
Accreditation Coordinator, Continuing Professional Education Department, MedscapeCME; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers, Baltimore City Public Schools, Baltimore, Maryland
Disclosure: Laurie E. Scudder, MS, NP, has disclosed no relevant financial relationships.
 

Have on hand valuable reference tools from the AGA Institute 2009 Spring Postgraduate Course.

Obtain new information about which patients should receive ablative therapy for Barrett’s esophagus, when to switch or stop biologics in IBD, how to tailor therapies to improve outcomes for hepatitis C and whether capsule endoscopy plays a role in functional bowel diseases.

This subscription-based product allows you to:

• View lectures along with clinical challenge sessions. (including audio and slides)
• Earn CME credit.
• Easily search by author, subject or session type.

Prices:
Members: $35
Nonmembers: $50

Order today!

Current purchasers, access sessions now with your user ID.

This activity has been approved for AMA PRA Category 1 Credit™.

As a part of the Hepatitis C Resource Center, this video roundtable is structured like a TV broadcast, lasting approximately 25-30 minute  featuring a panel of key opinion leaders discussing the latest clinical data and how it can be translated into management strategies to optimize care for patients with hepatitis C.

About the Hepatitis C Resource Center

The Hepatitis C Resource Center is designed to provide health-care providers data which has been translated into practical ways that can help them change how they diagnose and treat patients with hepatitis C.
 

Upon completion of this activity, participants will be able to:

• Discuss the present and anticipated future disease burden of chronic hepatitis C.
• Recognize the importance of early diagnosis and treatment in hepatitis C.
• Describe the potential of emerging therapeutic options for improving treatment response/outcomes and reducing disease burden in HCV-infected patients .

This activity is supported by individual education grant from Vertex Pharmaceuticals Inc.

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s) ™ . Each physician should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Zobair M Younossi, MD, MPH
Executive Director of Research; Executive Director, Center for Liver Diseases; Professor of Medicine, VCU-Inova Campus, Inova Health System, Falls Church, Virginia
Disclosures: Zobair M. Younossi, MD, MPH, has disclosed the following relevant financial relationships:
Received grant/research support from: Vertex Pharmaceuticals Incorporated; Schering-Plough Corporation; Roche Laboratories Inc.; Human Genome Sciences, Inc.; Biolex; Wyeth Pharmaceuticals Inc.; Gilead Sciences, Inc.

Hashem B El-Serag, MD, MPH
Professor of Medicine, Baylor College of Medicine, Houston, Texas
Disclosure: Hashem B. El-Serag, MD, MPH, has disclosed the following relevant financial relationships:
Received grant/research support from: Schering-Plough Corporation and Bayer HealthCare Pharmaceuticals.
Served as a consultant to: Vertex Pharmaceuticals Incorporated.

Maria L. Gaiso, PhD
Scientific Director, MedscapeCME
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.

Laurie Scudder, MS, NP
Laurie E. Scudder, MS, NP, Accreditation Coordinator, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers, Baltimore City Public Schools, Baltimore, Maryland
Disclosure: Laurie Scudder, MS, NP, has disclosed no relevant financial information.

The GI SAM series of online self-Assessments modules is an interactive, intuitive product that will assess your current knowledge of specific gastroenterology and hepatology-related topics. The complete series will include eight modules covering 16 topics, offering you access to a wide variety of GI and hepatology topics. The first module on the topics of IBD and GI Bleeding is available NOW!

Pricing (per module):
Member: $40
Member Trainee: $20
Nonmember: $50

View a demo of GI SAM.

Purchase now.

Upon completing this educational activity, successful learners will be able to:

• Identify their own knowledge gaps.
• Apply new knowledge to their practice.
• Compare their knowledge to that of their peers.

Each GI SAM module includes

• Goes through continuous author review and updates for ongoing accuracy and updated treatment protocols.
• Up to 10 AMA PRA Category 1 Credits^TM and 10 points towards ABIM Maintenance of Certification (MOC).
• 25 questions with instant feedback.
• References for further study.
• Detailed images and videos to further clarify important points.
• A detailed score report identifying areas where further review is needed.
• Can be accessed anytime, anywhere.

John F. Kuemmerle, Jr., MD, AGAF
Professor of Medicine and Physiology
Associate Chair of GI Research
Medical College of Virginia Campus
Virginia Commonwealth University

John F. Kuemmerle, Jr., MD, AGAF
Professor of Medicine and Physiology
Associate Chair of GI Research
Medical College of Virginia Campus
Virginia Commonwealth University

Amar Deshpande, MD
Assistant Professor of Clinical Medicine
University of Miami School of Medicine

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

As a part of the Hepatitis C Resource Center, this CME Expert Column Series offers insight into a leading GI thought leader’s perspective on the proper screening of HCC in cirrhotic patients.

About the Hepatitis C Resource Center

The Hepatitis C Resource Center is designed to provide health-care providers data which has been translated into practical ways that can help them change how they diagnose and treat patients with hepatitis C.

View article.

• Discuss the present and anticipated future disease burden of hepatitis C.
• Recognize the importance of early diagnosis and treatment in hepatitis C.
• Describe the potential of emerging therapeutic options for improving treatment response/outcomes and reducing disease burden in HCV-infected patients.

Robert G. Gish, MD
Medical Director, Liver Transplant Program
Pacific Medical Center
San Fancisco, CA

Disclosures:
Consultant: Bristol-Myers Squibb, Gilead Sciences, Projects in Knowledge, Inc.

Sponsored by the AGA Institute. This program is supported in part through an independent educational grant from Vertex Pharmaceuticals.

Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement
The AGA Institute designates each webinar in this educational activity for a maximum of 0.50AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Produced in cooperation with the AGA Institute, UpToDate^® is a subscription-based clinical information resource available on the Web, CD-ROM and pocket PC handheld devices. Each month, a free topic is made available on the AGA Web site. This month’s free topic is:

• Management and treatment of hepatitis C in the HIV-infected patient

Nearly 232 physicians write more than 673 topic reviews for UpToDate in gastroenterology and hepatology alone. UpToDate provides gastroenterologists with access to more than 60,000 pages of original, peer-reviewed text, 160,000 MEDLINE abstracts, drug information and drug interactions databases, and hundreds of patient information handouts across 12 specialties. Moreover, UpToDate is used by tens of thousands of clinicians in more than 110 countries and by hundreds of premier medical institutions worldwide.

Order your subscription to UpToDate.

 Get an insider’s look at some of the hidden gems of the DDW® program! View short video clips on a wide range of topics with various AGA Institute poster presenters and speakers from DDW® 2009 on AGA’s YouTube™ channel. These clips were recorded during DDW® 2009 and posted to the site daily.

In addition, view more playlists and videos on AGA’s YouTube™ channel including monthly video journal abstracts and patient education materials.

Recorded on June 9, 2009, Byron Cryer, MD, professor of Internal Medicine – Digestive and Liver Diseases, University of Texas Southwestern, discussed the prevalence and prevention of NSAID-induced ulcers as well as strategies to reduce the risks from NSAIDs.

Listen today.

In addition to the Webinar, online resources are also available, each designed specifically to help you review and discuss the risks of NSAIDs with your patients, including:

• Printable fact sheet on NSAID risks.
• Guides for discussing potential risks with your patients.

View additional resources at www.connecttoprotect.com.

This program is supported through an unrestricted grant from Horizon Therapeutics.

This set of slides clarifies and summarizes the key data and information from the National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK) report titled The Burden of Digestive Diseases in the United States.

All 25 chapters of the report are conveniently summarized by topic into individual slide sets. This product includes a wealth of information for your personal review or for use in your own presentations!

***To Download slides of individual chapters, Right Click and Choose "Save Target As" or "Save Link As":

Chapter 1 - All Digestive Diseases
Chapter 2 - Gastrointestinal Infections
Chapter 3 - Viral Hepatitis
Chapter 4 - Digestive Cancers
Chapter 5 - Cancer of the Esophagus
Chapter 6 - Cancer of the Stomach
Chapter 7 - Cancer of the Small Intestine
Chapter 8 - Cancer of the Colon and Rectum
Chapter 9 - Primary Liver Cancer
Chapter 10 - Cancer of the Bile Ducts
Chapter 11 - Cancer of the Gallbladder
Chapter 12 - Cancer of the Pancreas
Chapter 13 - Hemorrhoids
Chapter 14 - Gastroesophageal Reflux Disease
Chapter 15 - Peptic Ulcer Disease
Chapter 16 - Functional Intestinal Disorders
Chapter 17 - Appendicitis
Chapter 18 - Abdominal Wall Hernia
Chapter 19 - Inflammatory Bowel Disease
Chapter 20 - Diverticular Disease
Chapter 21 - Liver Disease
Chapter 22 - Gallstones
Chapter 23 - Pancreatitis
Chapter 24 - Indications and Outcomes of Gastrointestinal Endoscopy
Chapter 25 - Costs of Digestive Diseases

***To Download a .zip file of the entire slide set, click the Download File button in the top or bottom right of this page.

These slides were edited and prepared by Dr. James Everhart of the NIDDK, National Institutes of Health.

*The full report and individual chapters are available from the NIDDK.

Examine your overall knowledge, experience, practice patters, demographic characteristics and attitudes in the management of GERD and acid-related disorders.

Test your knowledge through 30 questions on the treatment and management of GERD patients. At the completion, you will receive a report with clear and concise explanations for the correct answer. In addition, an extensive list of references will be available for further reading.

As an added bonus, the first 100 responders will be entered into a drawing for $100 towards a charity of their choice, in their name.

• Recite new evidence-based recommendations in the AGA Institute guidelines for GERD management and implement them in your practice.
• Determine when diagnostic testing is helpful for a patient with reflux symptoms and select the most appropriate diagnostic approach.
• Utilize recommended testing strategies to confirm a suspected diagnosis of GERD in a challenging patient and initiate an appropriate course of therapy.
• Assess the role of acid suppression therapy in patients with typical and extraesophageal symptoms of GERD.
• Cite limitations of current medications for acid suppression and identify future pharmacologic strategies to improve treatment.

David A. Peura, MD

Prateek Sharma, MD

This activity is supported by educational grants from:

Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals North America, Inc.

Examine your overall knowledge, experience, practice patterns, demographic characteristics, and attitudes in the management of irritable bowel syndrome (IBS) and chronic constipation.

Test your knowledge through 30 questions on the diagnosis and management of IBS and chronic constipation. At the completion, you will receive a report with clear and concise explanations for the correct answer. In addition, an extensive list of references will be available for further reading.

As an added bonus, the first 100 responders will be entered into a drawing to win $100 towards a charity of their choice, in their name.

• Implement current guidelines for diagnosing IBS and chronic constipation, which includes identifying alarm features suggestive of organic disease and choosing diagnostic tests according to the latest evidence.
• Identify changes in guidelines for IBS management since the previous guidelines and integrate the latest evidence-based recommendations for appropriate nonpharmacologic and pharmacologic therapy for IBS and chronic constipation.

Brooks D. Cash, MD, FACG, FACP

William D. Chey, MD, AGAF, FACG, FACP

This activity is supported by educational grants from:

Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals North America, Inc.

Listen in to an overview on electronic prescribing, its benefits, key drivers that are encouraging its use – including the Medicare E-Prescribing Incentive Program – and best practices for implementation.

Listen and view the slides here.

To prepare your practice for e-Perscribing, take a free assessment at www.GetRxConnected.org/AGA.

On April 13, Mark DeLegge, MD, AGAF, author of the recently released online modules, Obesity for the Gastroenterologist and Nutrition in the Patient with Liver Disease, reviewed these modules and addressed any questions participants may have had about the information provided as well as other questions related to the topics that were not covered within the modules.

Audio is available to AGA members only. Listen to the audio from this call now.

This program provides a comprehensive, online education resource for health-care professionals focusing on improving patient care and the quality of life of patients with IBS-C and CC.

New topics include:

• Advancing drug treatment in IBS-C.
• Dysmotility and lower GI function.
• The role of water and electrolyte absorption in the GI tract.
• Treatment evolution and CC.

Sucampo Pharmaceuticals, Inc.

Takeda Pharmaceuticals North America, Inc.

The AGA Institute has launched www.TheGut.org , a gateway offering GI professionals greater and easier access to CME programming. The site will house programs that have been developed by ACCME-accredited organizations other than the AGA Institute. Topics will cover the full spectrum including IBD, new technology, gastrointestinal cancer and practice management. The AGA Institute is not involved in content development but reviews all programs posted on the site. Postings are available for viewing for up to one year.
 

To view additional topics, visit www.TheGut.org.

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.

For further information or to submit a program for consideration, please contact Dianne Bach (301) 941-2623 or Michael Stolar (301) 941-2608.

The 2009 Clinical Congress took place in Las Vegas, NV from Jan. 23-25, 2009. Most of the presentations from the general sessions are available in online.

*Only available for AGA members

Access Sessions

Nicholas J. Shaheen, MD, MPH, AGAF
University of North Carolina School of Medicine

William D. Chey, MD, AGAF, FACG
University of Michigan Health Systems

Various

Obesity is a significant risk factor for several gastrointestinal (GI) disorders with large economic burdens. Reducing the risk of obesity should be part of the gastroenterologist's management strategy in the treatment or prevention of these disorders.

AGA Institute has released two online modules to enhance your knowledge about the role of nutrition and obesity in gastroenterology.

• Obesity for the Gastroenterologist — Includes an overview of dietary, behavioral, drug and surgical management options for successful weight loss and maintenance.
• Nutrition in the Patient with Liver Disease — Reviews key factors in identifying malnutrition in liver disease patients and options for ensuring proper nutrition in those patients.
  

Each online module includes slides with corresponding audio delivered by subject experts as well as, pre- and post-test questions. A score report will be provided upon completion.

The modules are part of the Nutrition Toolkit Series, a component of the AGA Institute’s nutrition and obesity initiative. The initiative will include access to AGA Institute obesity-related educational materials and suggested Web sites that offer tools such as nutritional calculators and meal planning tips. Additional modules on obesity and nutrition related issues are in development and will be made available throughout the year.

Available only to AGA members. To become a member, visit www.gastro.org/membership today.

Mark H. DeLegge, MD, AGAF
Professor of Medicine
Digestive Disease Center
Medical University of South Carolina

On March 24, the AGA hosted a free teleconference with CMS representatives on Medicare’s Recovery Audit Contractor (RAC) program.

During this call, CMS provided an overview of the background and goals of the national RAC program. Cecile Katzoff, MGA, CGCS, vice president, AGA consulting services, provided useful tips on how gastroenterology practices can prepare for RAC audits, including potential areas of RAC reviews for GI practices and ways to ensure proper coding and documentation to minimize the potential for repayment of claims to the Medicare program. If you were unable to attend, you can listen to the an audio recording from this conference online.

Download the slides:
Part 1
Part 2

Additional Q&A from RAC Call
 

This program will provide clinicians with up-to-the minute information on the long-term efficacy and safety outcomes with biologic therapy.

At the end of this educational activity, participants should be able to:

• Assess the benefit of early initiation of medical therapy to improve clinical outcomes in patients with Crohn’s disease.
• Cite the use of biologics in the treatment of Crohn’s disease, particularly with respect to patient-related outcomes and improvements in quality-of-life.
• Apply the latest clinical trial data to maximizing patients’ long-term response to anti-TNF therapy.
• Determine the appropriate strategies for when to switch patients from one anti-TNF agent to another.
• Evaluate the safety and efficacy of evolving therapies, specifically anti-TNF agents, for the long-term treatment of Crohn’s disease.

UCB, Inc.

The AGA Institute has launched www.TheGut.org , a gateway offering GI professionals greater and easier access to CME programming. The site will house programs that have been developed by ACCME-accredited organizations other than the AGA Institute. Topics will cover the full spectrum including IBD, new technology, gastrointestinal cancer and practice management. The AGA Institute is not involved in content development but reviews all programs posted on the site. Postings are available for viewing for up to one year.

To view additional topics, visit www.TheGut.org.

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.
 

For further information or to submit a program for consideration, please contact Dianne Bach (301) 941-2623 or Michael Stolar (301) 941-2608.

This program contains five presentations from the AGA Institute ’s fourth annual course for non-physician providers, entitled 2008 Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant, held August 17 - 21, 2008 in Montreal, Canada. This program has been designated for up to 3.75 hours of continuing education credit by the American Academy of Nurse Practitioners and the American Academy of Physician Assistants. The program topics were selected based on attendees' evaluations from the course and are direct audio recordings and slides from the following sessions:

• Evaluation and Management of Motility Disorders
• Managing Inflammatory Bowel Disorders
• The Mid-Level Provider as Hospitalist
• Pediatric Gastroenterology
• Women's Health and GI

Sucampo Pharmaceuticals, Inc.

Takeda Pharmaceuticals North America, Inc.

AAPA issues the CME credit and AANP issues the CE credit for this program.

At the end of this educational activity, participants should be able to:

• Describe current treatment algorithm guidelines in the management of patients with Crohn's disease.
• Assess the benefit-risk profiles of new treatment options for Crohn's disease.
• Identify the potential for neurologic and demyelinating disorders that may be associated with use of biologics in Crohn's disease.
• Demonstrate the knowledge of how to integrate new therapies into treatment strategies to improve patient outcome.

William J. Sandborn, MD
Maria T. Abreu, MD
David W. Brandes, MD
Remo Panaccione, MD

Elan Pharmaceuticals, Inc.

Biogen Idec

The AGA Institute has launched www.TheGut.org, a gateway offering GI professionals greater and easier access to CME programming. The site will house programs that have been developed by ACCME-accredited organizations other than the AGA Institute. Topics will cover the full spectrum including IBD, new technology, gastrointestinal cancer and practice management. The AGA Institute is not involved in content development but reviews all programs posted on the site. Postings are available for viewing for up to one year.
 

To view additional topics, visit www.TheGut.org .

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.
 

For further information or to submit a program for consideration, please contact Dianne Bach (301) 941-2623 or Michael Stolar (301) 941-2608.

The Centers for Medicare and Medicaid Services (CMS), along with the AGA Institute hosted a Special Open Door Forum on Sept. 23, 2008 to discuss participation in the 2008 and future Physician Quality Reporting Initiative (PQRI) programs. The purpose of this Forum was to encourage PQRI participation and provide simple steps that GI practices can use to collect and report quality data to be eligible for an incentive payment from CMS.

View Transcript

Download Conference Slides PPT

Mary Igo, RN, MBA
Joel Brill, MD, AGAF
Daniel Green, MD (CMS representative)

This program provides a comprehensive, online education resource for health-care professionals focusing on improving patient care and the quality-of-life of patients with IBS-C and CC.

At the conclusion of this entire activity, participants should be able to:

• Describe the epidemiology, demographics and risk factors associated with CC and IBS-C.
• Relate the pathophysiology of these conditions to the presentation of the patient’s symptoms and to describe the potential for overlap in the etiology of these conditions.
• Develop a confident in-office diagnosis of CC, or of IBS, on the basis of the patient’s symptom complex.
• Identify alarm features and appreciate when to refer patients for specialist evaluation.
• Determine what hospital-based tests offer the greatest diagnostic yield.
• Empathize with patients’ concerns about their symptoms and recognize what is likely to bother patients most about their condition.
• Evaluate the evidence for current treatments and describe the current best practice in the management of CC and IBS (both in typical patients and in subgroups of patients, such as the elderly, etc.).

To view additional topics, visit TheGut.org.

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.

For further information or to submit a program for consideration, please contact Dianne Bach (301) 941-2623 or Michael Stolar (301) 941-2608

The program will address important esophageal disorders in juniors and adolescents, in mid-life, and in seniors.

At the conclusion of this activity, participants should be able to:

• Recognize the significance of esophageal eosinophilia in children, and in adults, the overlap between GERD and eosinophilic esophagitis and the implications for treatment.
• Describe the association of obesity, GERD, Barrett’s esophagus and esophageal adenocarcinoma.
• Determine that prolonged nocturnal acid exposure — if inadequately treated — can lead to serious esophageal complications such as high grade GERD, stricture, Barrett’s esophagus, and esophageal adenocarcinoma.
• Recognize patients with non-cardiac chest pain and appreciate the indications for investigation and anti-secretory treatment.
• Explain that acid secretion continues into late adulthood and that acid reflux can be at least as damaging in the elderly as the young, even though there may be relatively lower levels of symptom perception.
• Define the role of the new generation of PPI treatment, which offers prolonged acid suppression and freedom from dosing in relation to food.

Loren Laine

Sucampo Pharmaceuticals, Inc.

Takeda Pharmaceuticals North America, Inc.

The AGA Institute has launched TheGut.org, a gateway offering GI professionals greater and easier access to CME programming. The site will house programs that have been developed by ACCME-accredited organizations other than the AGA Institute. Topics will cover the full spectrum including IBD, new technology, gastrointestinal cancer and practice management. The AGA Institute is not involved in content development but reviews all programs posted on the site. Postings are available for viewing for up to one year.

To view topics, visit TheGut.org.

All programs are produced by ACCME-accredited organizations. The programs are not changed in any way by the AGA Institute and AGA Insitute assumes no responsibility for the content.

For further information or to submit a program for consideration, please contact Dianne Bach (301) 941-2623 or Michael Stolar (301) 941-2608.

As the field of endoscopic sedation experiences rapid change, the SedationFacts Web site offers practicing Gastroenterologists, Gastroenterology nurses and Gastroenterology fellows a comprehensive resource for current, objective, evidence-based information concerning endoscopic sedation.

Updated regularly, this Web site was created to provide Gastroenterology clinicians information that can sustain and improve patient safety associated with endoscopic sedation. Physicians, nurses and fellows are invited to use SedationFacts.org to access articles by leading Gastroenterology physicians and nurses, find in-depth information on the physiology and pharmacology of endoscopic sedation, and get helpful links to current practice guidelines and regulations.

Go to SedationFacts.org

ReachMD XM 160 is the channel for medical professionals and brings you educational news and information on satellite radio, online and on-demand.

GI Insights, broadcasted through ReachMD XM 160, features the field’s top gastroenterologists discussing today’s issues. Each week a new topic will air.

Each program will be broadcasted twice per day for the first week it is released. View broadcast schedule.

Listen today!

This series of programs is sponsored by Takeda Pharmaceuticals North America, Inc.

This program contains five presentations from the AGA Institute ’s third annual course for non-physician providers, entitled 2007 Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant, held August 5 - 9, 2007 in San Francisco, CA. This program has been designated for up to 4.5 hours of continuing education credit by the American Academy of Nurse Practitioners and the American Academy of Physician Assistants. The program topics were selected based on attendees' evaluations from the course and are direct audio recordings and slides from the following sessions:

• New Therapies in Liver Disease: HCV, HBV, HE Update
• Update on Diagnosis and Treatment of GERD
• GI Bleeding Evaluation and Management
• New Technologies in Colorectal Cancer Screening
• Overview of Gut Motility

This activity is supported by an educational grant from TAP Pharmaceutical Products, Inc.

AAPA issues the CME credit and AANP issues the CE credit for this program.

The second annual Fellows’ Nutrition Course was held in November 2007. This exciting program selected 40 GI fellows to attend two–and–a–half days of lectures and hands–on demonstrations about basic nutrition. All participants had the unique opportunity to meet and network with peers who shared a similar interest in nutrition.

Topics covered include:

Basic Nutrition

• Carbohydrates – Absorption and Metabolism Kelly Tappenden, RD, PhD
• Protein and Energy Requirements Robert Kushner, MD
• Fats – Absorption, and Metabolism Kelly Tappenden, RD, PhD
• Dietary Fiber, Prebiotics and Probiotics Martin Floch, MD
• Body Composition & Practical Nutritional Assessment Khursheed Jeejeebhoy, MBBS, PhD
• Vitamins – Water Soluble Deficiencies Andrew Ukleja, MD
• Vitamins – Fat Soluble Deficiencies Andrew Ukleja, MD
• Trace Metals Craig McClain, MD

Clinical Consequences of Under and Over Nutrition

• Anthropometrics in Obesity Robert Kushner, MD
• The Thin Patient: Fit as a Fiddle or Malnourished? Carol Semrad, MD
• Obesity – Medical Management Robert Kushner, MD
• Obesity – Surgical Management Eric Hungness, MD
• Medical Complications of Bariatric Surgery Jeanette Keith, MD
• Endoscopic Management of Obesity John Martin, MD
• Malnutrition, Starvation and Refeeding Syndrome Khursheed Jeejeebhoy, MBBS, PhD
• Malabsorption John DiBaise, MD
• The Celiac Patient Carol Semrad, MD

Nutrition in Gastrointestinal Disease

• The Liver Patient and Alcohol Craig McClain, MD
• Hepatic Failure John DiBaise, MD
• Acute Pancreatitis Stephen McClave, MD
• Chronic Pancreatitis John Martin, MD

Parenteral and Enteral Nutrition

• Indications for PPN and TPN James Scolapio, MD
• Stress and the Critical Care Unit Patient Thomas Ziegler, MD
• Complications of Enteral Nutrition Stephen McClave, MD Part 1, Part 2, Part 3
• Workshop-TPN&EN: Indications, Ordering, and Monitoring the Patient: Alan Buchman, MD, MSPH; James Scolapio, MD; Thomas Ziegler, MD

Formulas, Metabolism, and Special Clinical Conditions

• Creating the Parenteral Formula Mark DeLegge, MD
• Micronutrient Requirements and Deficiencies Douglas Seidner, MD
• Enteral Formulas – How Much and Which Mark DeLegge, MD
• Nutrition in the Elderly Joel Mason, MD
• Nutrition in the Patient with Anorexia and Cachexia Jeanette Keith, MD
• Nutrition and the Cancer Patient Joel Mason, MD
• Metabolic Bone Disease and Gastrointestinal Illness Douglas Seidner, MD
• Intestinal Transplant and Non-Transplant Surgery Jon Fryer, MD

Martin Floch, MD

Alan Buchman, MD, MSPH

James Scolapio, MD

Nestle Nutrition Institute

Several states, including New York, have put forth requirements for medical practices that perform endoscopy procedures in their office to be accredited by a recognized organization (Accreditation Association for Ambulatory Health Care, Inc. (AAAHC), Joint Commission, etc.). The AGA Institute is also in the process of developing policies and procedures for office surgery, and additional tools and products that will simplify the accreditation process.

Questions and Answers

Cecile Katzoff, MGA, CGCS
AGA Vice President for Practice Management and Consulting
Services Bethesda, MD

Peter S. Donaldson, MBA
Digestive Health Specialists, PA
Winston-Salem, NC

Lawrence S. Kim, MD
South Denver Gastroenterology
Denver, CO

Kathy J Sammis, CEO/CFO
Charlotte Gastroenterology & Hepatology
Charlotte, NC

Janet M. Jerhada
Drs. Kornbluth, George and Legnani
New York, NY

Mike Dye
Ambulatory Care & Office-Based Surgery
Business Development
The Joint Commission

Joel Brill, MD
AGA Practice Management and Economics Committee
Scottsdale, AZ

On Oct. 22, 2007 individuals who have gone through the accreditation process and representatives from AAAHC, Joint Commission and other experts, spoke on what accreditation means for your practice.

This easy-to-read monograph contains transcripts of popular AGA Institute Focused Clinical Update (FCU) breakfast sessions held at DDW® 2007.

For 15 key clinical areas, expert moderators select and analyze 10 of the most interesting and significant clinical research abstracts presented at DDW.

Topics include:

• Acid Reflux, Nonacid Reflux and Functional Heartburn
• Capsule Endoscopy
• Celiac Disease
• Diagnosis and Treatment of Gastroparesis
• Emerging Therapies for IBD
• Endoscopic Ultrasonography
• Enteral and Parenteral Feeding
• Irritable Bowel Syndrome
• NAFLD
• Novel Treatments for Dyspepsia
• NSAIDs, Aspirin and other Anti-platelet Drugs
• Pancreatic Neoplasia
• Pelvic Floor Dysfunction and Anorectal Motility Disorders
• Prebiotics and Probiotics
• The Treatment of Obesity

Various

TAP Pharmaceutical Products, Inc.

During the bi-annual GI Training Directors Workshop, held March 2 - 4, 2007, presentations focused on key issues involved in running a successful training program and to identify solutions to common challenges. Experts in the field of training addressed topics ranging from how to improve the application process and the GI Match to how to integrate new research into training and keep trainees updated on new technologies. The event is sponsored by the AGA Institute, the American Association for the Study of Liver Disease (AASLD), the American College of Gastroenterology (ACG), and the American Society for Gastrointestinal Endoscopy (ASGE).

Improving the Application Process and the GI Match - Application Process, Universal Application, ERAS
Deborah Proctor, MD

Hot Topics from the Training Directors’ Survey (slides) (summary)
Don Rockey, MD, Facilitator

Case Study: Teaching New Technologies
John J. Vargo, II, MD, MPH and Jack DiPalma, MD, Moderators

Case Study: Dealing with Family Issues, Work Hours
Deborah Procter, MD and Lawrence Schiller, MD, Moderators

The Gastroenterology Core Curriculum
M. Michael Wolfe, MD

An Update from the ABIM
Lawrence Friedman, MD, Chair, Subspecialty Board on Gastroenterology

The Future of Internal Medicine: Training and its Effects on Gastroenterology
Steven Weinberger, MD, American College of Physicians

Training the Trainer: Lessons from the WGO
Eamonn Quigley, MD

Don C. Rockey, MD
Chief, Division of Digestive & Liver Diseases
University of Texas Southwestern Medical Center
Dallas, TX

Lawrence S. Schiller, MD
Program Director, Gastroenterology Fellowship
Baylor University Medical Center
Dallas, TX

Currently, the AGA Institute provides journal CME for the Gastroenterology and Clinical Gastroenterology and Hepatology journals.

Gastroenterology and Clinical Gastroenterology and Hepatology CME Program:

Each CME exercise consists of a single test with short questions followed by a brief post-test evaluation. Each exam is based on a single article published in Gastroenterology and/or Clinical Gastroenterology and Hepatology. To start an exercise, select an article from the list on the Web site. You may complete the exercise in one sitting or you may save your work in progress and complete it at a later date. You may create a free personal account to return to your work in progress and track your progress through the program.

Gastroenterology  |  Clinical Gastroenterology and Hepatology

Various

Summary
The first annual Fellows’ Nutrition Course was held in November 2006. This exciting program selected 40 second-year GI fellows to attend two-and-a-half days of lectures and hands-on demonstrations about basic nutrition. All participants had the unique opportunity to meet and network with peers who shared a similar interest in nutrition.

About
You may download the audio from the course and the corresponding syllabus section. Materials include:

Friday, Nov. 10, 2006

Basic Nutrition PDF

• Carbohydrates - Absorption and Metabolism by Jeanette Keith, MD
• Protein and Energy Requirements by Khursheed Jeejeebhoy, MBBS, PhD
• Fats – Absorption, and Metabolism by Jeanette Keith, MD
• Dietary Fiber, Prebiotics and Probiotics by Martin Floch, MD
• Body Composition & Practical Nutritional Assessment by Khursheed Jeejeebhoy, MBBS, PhD
• Vitamins – Water / Fat Soluble Deficiencies by Andrew Ukleja, MD

Clinical Consequences of Under and Over Nutrition PDF

• The BMI, Weight COntrol, Diet History and Diet Prescription by Lee Kaplan, MD, PhD (Workshop)
• Obesity – Medical Management by Lee Kaplan, MD, PhD
• Obesity – Surgical Management and GI Complications by Andrew Ukleja, MD
• Malnutrition, Starvation and Refeeding Syndrome by Khursheed Jeejeebhoy, MBBS, PhD
• Malabsorption by Robert Craig, MD
• The Diabetic Patient by Patricia Sheean, PhD, RD
• Diet History, Therepeutic Diets by Patricia Sheean, PhD, RD
• The Celiac Patient by Robert Craig, MD

Saturday, Nov. 11, 2006

Nutrition in Gastrointestinal Disease PDF

• The Liver Patient and Alcohol by Jaime Aranda-Michel, MD
• Hepatic Failure by Jaime Aranda-Michel, MD
• Acute Pancreatitis by Stephen McClave, MD
  
• Short-Bowel Syndrome and Bacterial Overgrowth by James Scolapio, MD
• Food Intolerances and Hypersensitivities by Scott Sicherer, MD

Parenteral and Enteral Nutrition PDF

• Indications for PPN and TPN by James Scolapio, MD
• Stress and the Critical Care Unit Patient by Stephen McClave, MD
• Complications of Enteral and Parenteral Nutrition by Alan Buchman, MD, MSPH
• Medical and Legal Issues of Nutrition Support by Albert Barrocas, MD
• Discussions/Case Examples of Nutrition Decisions (Workshop)

Sunday, Nov. 12, 2006

Formulas, Metabolism, and Special Clinical Conditions 

• Creating the Parenteral Formula by Mark DeLegge, MD
• Micronutrient Requirements and Deficiencies by Craig McClain, MD
• Enteral Formulas — How Much and Which by Mark DeLegge, MD
• Home Parenteral Nutrition and Transplant Support by Alan Buchman, MD, MSPH
• Metabolic Bone Disease and Gastrointestinal Illness by Douglas Seidner, MD
• Clinical Implications of Oxidative Stress and Antioxidant Therapy by Craig McClain, MD
• Nutrition in the Elderly by Rosemarie Fisher, MD
• Nutrition and the Cancer Patient Anorexia and Cachexia by Douglas Seidner, MD

Nestle Nutrition Institute